MAP2 and endometrial cancer: Using the GEPIA2 online tool and gene expression data from 170 endometrial adenocarcinomas, Spearman rank correlation revealed a positive association of DSCAM-AS1 with the 4.7-fold downregulated tumor-promoting gene ELL2 (rho = 0.42, p = 3.5 × 10−9) and with the downregulated tumor-promoting genes UNC13D (FHL3, Munc13-4) (rho = 0.39, p = 3 × 10−8) and MAP2 (rho = 0.4, p = 1.7 × 10−11) in endometrial cancer tissues (Figure S4).